Zain Kassam

Co-Founder, Finch Therapeutics
When
27th-28th Oct 2022
Where
Miami, FL
Hyatt Regency Miami
“We are all set to welcome you im Miami at the end of October. You can book your place now, confident that you will enjoy great networking and learning experience that only comes from in-person, face-to-face meetings.”
Steve Hambrook, CEO, Global Engage
Be a part of a meeting that brings together academic, industry and investment leaders to discuss the cutting-edge developments in microbiome, skin & probiotic research. Together you will explore the challenges and opportunities in translating research toward commercialisation, as well as learning how partnerships and collaborations can secure investment. Topics covered include gut health and disease, as well as the stunning advances being made in understanding the gut-brain axis. There are also dedicated tracks devoted to developments in Probiotics, Prebiotics and Postbiotic research as well as personalised nutrition.
New for 2022 is expanded coverage of Women’s health, LBP, advances in HMO & infant health and research in metabolic diseases
This world-renowned meeting provides a networking experience in which industry/academia collaborations are forged to translate research into clinical trials. Plus, the attendees have ample opportunity to review more than 30 poster presentations and meet with 30+ exhibitors showcasing the latest products and services.
“The talks I went to had real content (data, innovative ideas, business impact)”
“I met people from all areas in this growing industry… academia, pharma and consumer products”
“Deeper understanding of product concepts – especially clinical relevance and application to health outcomes”
“Excellent speakers … a mix of research and business focussed talks”
Don’t forget your ticket also gives you access to the 4th Skin Microbiome & Cosmeceuticals Congress: USA
Featured speakers:
This program is designed to create a collaborative environment in which delegates can forge enduring relationships across the full range of microbiome and probiotic research.
Find out about our sustainability values.
Skin Health & the Microbiome
Cosmetics and Commercial Strategy
Co-Founder & CEO, Microbiome Insights, Inc., Canada
VP Scientific Affairs, Danone
Chief Scientific Officer, Coty inc
CEO, Lactobio
Partner and co-leader Advertising, Marketing and Digital Media team, BakerHostetler
Director, Microbiome Core Facility, UNC Chapel Hill
CEO & Co-Founder, Exelio Bio
University of Washington
Assistant Professor, Div. Gastroenterology, Dept. Medicine, UC San Diego
Co-Chair, Advertising Disputes; Chair, Retail & Consumer Brands, Loeb & Loeb
Scientific and Regulatory Affairs, Project Manager, Morinaga
Associate Professor, Genetics and Genomic Sciences, Mount Sinai School of Medicine
,Associate Professor, Genomic Medicine and Infectious Diseases, JCVI
Associate Director, Resiliency & Well-being Center, Program Director, Integrative Medicine (INTM) Executive Director, Office of INTM & Health, George Washington University School of Medicine and Health Sciences (SMHS)
Grace Park, VP of R&D, ELSI Skin Health
Global Regulatory Strategy Lead, Health Dietary Supplements, IFF
VP Bioprocess & Development, Adiso
VP Research, Rise Therapeutics
Chief Medical Officer, Biotia; Research Assistant Professor at SUNY Downstate Health Sciences University
Director of Product Development, Arcaea
Assistant Professor of Biochemistry and Molecular Biology, The Pennsylvania State University
Chief Medical Officer, IFF
President and CEO, MatriSys Bioscience, Inc.
VP, Manufacturing, Rise Therapeutics
Scientist, Living Cellular Devices Platform, Wyss Institute at Harvard University
Technical Adviser, COSMAX
CEO and Founder, Cybele Microbiome Inc
Head of Clinical and Scientific Affairs, Burt’s Bees
Co-Founder, Finch Therapeutics
CSO and Founder, Symbiome
Deputy Manager, Manda Fermentation Co. Ltd.
Founder and CEO, ImmuneBiotech AB
CSO, Clinical Microbiomics
Founder and CEO, OptiBiotix Health plc
President & CEO, AOBiome
Director Research Collaborations, Washington University School of Medicine in St. Louis
Professor, Department of Microbiology and Cell Science, University of Florida
Adam Baker, Director of Science, Human Health, Chr. Hansen
Group Leader, Complex Microbial Systems, National Institute of Standards and Technology (NIST), USA
CSO, Viome
Head of Clinical Development, Chr. Hansen
Chief Scientific Officer, Azitra
Assistant Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Investment Advisor, Seventrue Partners
Professor, University of Alberta, Canada
CEO, Phi Therapeutics, USA
Founder, VGAM Biosciences
Associate Professor of Medicine in the Division of Gastroenterology and Hepatology, Mayo Clinic
Research Technical Leader, Life Science, Kimberly-Clark
Co-Founder/ Principal Scientist, BCD Bioscience
CEO, MRM Health
Chief Science Officer, Synbiotic Health
Chief Scientific Officer, Arranta Bio
Assistant Professor, Johns Hopkins Bloomberg School of Public Health
Co-Founder & CEO, Concerto Bioscience
Vice President, National Adverting Division, BBB National Programs
Co-Founder/CEO, Sequential Skin
Associate Professor, Department of Nutrition and Integrative Physiology, University of Utah
Co-Founder & CEO, Microbiome Insights, Inc., Canada
VP Scientific Affairs, Danone
Chief Scientific Officer, Coty inc
CEO, Lactobio
Partner and co-leader Advertising, Marketing and Digital Media team, BakerHostetler
Director, Microbiome Core Facility, UNC Chapel Hill
CEO & Co-Founder, Exelio Bio
University of Washington
Assistant Professor, Div. Gastroenterology, Dept. Medicine, UC San Diego
Co-Chair, Advertising Disputes; Chair, Retail & Consumer Brands, Loeb & Loeb
Scientific and Regulatory Affairs, Project Manager, Morinaga
Associate Professor, Genetics and Genomic Sciences, Mount Sinai School of Medicine
,Associate Professor, Genomic Medicine and Infectious Diseases, JCVI
Associate Director, Resiliency & Well-being Center, Program Director, Integrative Medicine (INTM) Executive Director, Office of INTM & Health, George Washington University School of Medicine and Health Sciences (SMHS)
Grace Park, VP of R&D, ELSI Skin Health
Global Regulatory Strategy Lead, Health Dietary Supplements, IFF
VP Bioprocess & Development, Adiso
VP Research, Rise Therapeutics
Chief Medical Officer, Biotia; Research Assistant Professor at SUNY Downstate Health Sciences University
Director of Product Development, Arcaea
Assistant Professor of Biochemistry and Molecular Biology, The Pennsylvania State University
Chief Medical Officer, IFF
President and CEO, MatriSys Bioscience, Inc.
VP, Manufacturing, Rise Therapeutics
Scientist, Living Cellular Devices Platform, Wyss Institute at Harvard University
Technical Adviser, COSMAX
CEO and Founder, Cybele Microbiome Inc
Head of Clinical and Scientific Affairs, Burt’s Bees
Co-Founder, Finch Therapeutics
CSO and Founder, Symbiome
Deputy Manager, Manda Fermentation Co. Ltd.
Founder and CEO, ImmuneBiotech AB
CSO, Clinical Microbiomics
Founder and CEO, OptiBiotix Health plc
President & CEO, AOBiome
Director Research Collaborations, Washington University School of Medicine in St. Louis
Professor, Department of Microbiology and Cell Science, University of Florida
Adam Baker, Director of Science, Human Health, Chr. Hansen
Group Leader, Complex Microbial Systems, National Institute of Standards and Technology (NIST), USA
CSO, Viome
Head of Clinical Development, Chr. Hansen
Chief Scientific Officer, Azitra
Assistant Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Investment Advisor, Seventrue Partners
Professor, University of Alberta, Canada
CEO, Phi Therapeutics, USA
Founder, VGAM Biosciences
Associate Professor of Medicine in the Division of Gastroenterology and Hepatology, Mayo Clinic
Research Technical Leader, Life Science, Kimberly-Clark
Co-Founder/ Principal Scientist, BCD Bioscience
CEO, MRM Health
Chief Science Officer, Synbiotic Health
Chief Scientific Officer, Arranta Bio
Assistant Professor, Johns Hopkins Bloomberg School of Public Health
Co-Founder & CEO, Concerto Bioscience
Vice President, National Adverting Division, BBB National Programs
Co-Founder/CEO, Sequential Skin
Associate Professor, Department of Nutrition and Integrative Physiology, University of Utah
10th Microbiome & Probiotics R&D and Business Collaboration Forum USA | ||||
Room 1 | Room 2 | Room 3 | Room 4 | |
October 27 | Gut Health & Disease (Gastro Disorders C.diff) |
Tool & Technologies | Probiotics & Prebiotics | Skin & cosmeceuticals |
October 28 | Gut Health & Disease (Metabolic Disorders etc) |
LBP Manufacturing, Regulations, & Investment | Personalized Nutrition | Skin & cosmeceuticals |
Download the Meeting Agenda
400 South East Second Avenue, Miami, Florida, United States, 33131-2197
>
The Hyatt Regency Miami is next to one of the trendiest neighborhoods in Miami, known as Brickell. The iconic white towers overlook the Miami River, and the hotel is connected to the James L. Knight Center. An ideal location that puts you steps from the Miami Riverwalk and close to the Port of Miami and FTX Arena (formerly known as American Airlines Arena). After the conference shop the Brickell City Centre or Bayside Market Place, explore Little Havana or tour the Frost Museum of Science.
Sign up to receive updates, news and speaker resources
Are you a start-up?
We have a number of special options for start-ups to be a part of the meeting. Contact Maria for the qualifying criteria.
3 for the price of 2 offer
Save with 5 passes Academic/Industry $300/$1000 per person
Discount applied automatically at registration. If you do not know the names of your attendees use this form to secure the discounts.
Not applicable for solution provider companies or compatible with any other offers or discount code
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone or email [email protected]
Option 2 – Please complete the form below to pay online
“You are about to be a part of a great networking meeting. I can’t wait to welcome you in person.”
Steve Hambrook, CEO, Global Engage
Organisations offering services and/or business & technology solutions and business consultants please contact Gavin Hambrook to discuss participation at this meeting.
The fees shown are available to industry, academics and not for profit organisations.
To help us comply with GDPR (privacy regulations) please register using your official institution email address and not a personal email.
Are you a start-up? Contact [email protected] for innovative ways to join the meeting.
$1,699.00
Standard registration for those not in the categories below
$499.00
$1,899.00
Fee for representatives of organisations offering services and/or business & technology solutions and also to business consultants.
Poster presentation sessions will take place in breaks and alongside the other breakout sessions of the conference. Your presentation will be displayed in a dedicated area, with the other accepted posters from industry and academic presenters.
We also issue a poster eBook to all attendees containing your full abstract, and you can share your poster as a PDF after the meeting if you desire (optional).
Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, these are an excellent way to join the heart of this congress.
In order to present a poster at the forum, you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first-come-first-served basis (subject to checks and successful registration).
POSTER COMPETITION – CLOSING DATE October 7, 2022
Biose industrie is the worlds leading CDMO for Live Biotherapeutic products – Based in France we have over 30 different LBP programs being run out of our plant with well over a 100 different bacterial strains being developed or manaufactured at GMP level. 2022 will see us double our manufacturing volumes with even bigger expansion plnned in the next 3 years. Come and meet us at the event if you require support for your LBP program.
https://www.biose.com/
Labskin’s pioneering approach to testing skin care products by cloning a patient’s skin microbiome and transplanting it on to Labskin human skin equivalent allows a wide range of testing that no longer requires invasive procedures on patients. Data from next generation sequencing of the Labskin and skin biome is coupled with AI processes to interpret and direct further development of skincare products in a controlled and efficient manner, reducing development time and costs.
https://www.labskin.co.uk/
vermicon AG, the microbiology specialist from Munich, Germany, provides innovative technologies, specific microbiological expertise and cultivation-independent methods for the in situ identification, quantification and visualization of microorganisms directly at their site of action. By using FISH (Fluorescence In Situ Hybridization), Flow Cytometry, qPCR, NGS and individually adapted solutions, vermicon provides deeper and holistic understanding of the human microbiome and supports pharmaceutical companies and CDMOs involved in the development and production of microbiome-based therapeutics. The company services are GMP certified and include solutions for all stages of the production chain, from research and development to the final product.
https://www.vermicon.com/microbiome
Intralytix, Inc. is a biotechnology company focused on the discovery, production, and marketing of bacteriophage (phage)-based products to control specific bacterial pathogens in environmental, food processing, and medical settings, including oral care and skin care. The company is the largest producer of FDA-approved phage products for food safety applications in the world, with its state-of-the-art R&D and cGMP-compliant production facilities located in Columbia, Maryland.
www.intralytix.com
COSMAX Group is a global no.1 research, development and production business group for cosmetic and health functional food products.
Today, one quarter of the world’s 7 billion population use COSMAX. beauty products.
Across the globe, 600 beauty companies, including 15 of the world’s top 20 beauty companies, are in a partnership with COSMAX.
COSMAX Group, built around the global leader of K-Beauty, COSMAX, consists of COSMAX NBT and COSMAX BIO, companies specialized in the production of health functional foods and medical supplies. As a cosmetics manufacturer, and a company that develops and manufactures equipment as well as special packaging, we are interwoven and focused through each field and integration.
At the finest global research and production facilities located in Seoul (Korea), Shanghai and Guangzhou (China), Cleveland, Dallas, and New Jersey (United States), Victoria (Australia), Jakarta (Indonesia), and Bangkok (Thailand), COSMAX researches, develops, and manufactures high-quality products that are quickly produced and brought to market.
From planning, research and development of cosmetics, to health functional foods production, quality control and marketing support, the COSMAX Group moves forward, shoulder to shoulder, beside wide range of partners in global markets.
ENG https://cosmax.com/new/en/main.asp
KOR https://cosmax.com/main.asp
CHN https://cosmax.com/new/cn/main.asp
Microbiology International specializes in laboratory automation by providing advanced instruments and custom media solutions to the modern laboratory. Our advanced Whitley Workstations provide a strict anaerobic or precisely controlled atmosphere for gut microbiota applications. Features include no-bake catalyst, glove-free operation, maintenance-free humidity control, electronic conditions monitoring, touchscreen interface, transfer airlock, and more. Whatever your application, we can tailor the Whitley Workstation to your requirements. Stop by our booth for a demonstration.
https://800ezmicro.com/
Invitek Molecular offers complete solutions for reliable and validated microbiome sample management, from sample collection and stabilization to manual and automated DNA extraction.
With the Stool Collection Tubes, we offer a versatile tool for gut microbiome analysis, microbiome-associated disease research, nutrigenomics and veterinary studies. For oral microbiome studies, we offer several options for saliva and swab samples.
Our collection and extraction systems guarantee excellent performance in downstream NGS applications.
.
https://www.invitek-molecular.com/products/microbiome.html
Our sponsorship packages offer a wide range of attendance options to suit your budget and business needs in order to maximise return on investment.
If there is any other way you would like to sponsor or increase branding for your company at the event, please get in touch and we will be able to offer you a bespoke service.
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
Options include:
For further details please contact
Gavin Hambrook
Telephone +44 (0) 1865 849841 or
email [email protected]
Microbiome Research Reports (MRR) is an international peer-reviewed, open-access journal. All articles published by MRR are made freely and permanently accessible online immediately from the date of publication.
The scope of the journal includes investigations of microbiomes present in one or various body compartments of human beings or other animals. Surveys on the establishment of microbial communities as well as on microbe-microbe interactions and microbe-host communication will be considered for publication. The overall aim of MRR is to publish high-quality researches from scientists with a common interest in microbiome/microbiota research in all its multidisciplinary aspects.
×Beneficial Microbes is a peer-reviewed scientific journal with a specific area of focus: the promotion of the science of microbes beneficial to the health and wellbeing of man and animal. The journal contains original research papers and critical reviews in all areas dealing with beneficial microbes in both the small and large intestine, together with opinions, a calendar of forthcoming beneficial microbes-related events, and book reviews. The journal takes a multidisciplinary approach and focuses on a broad spectrum of issues, including safety aspects of pro- & prebiotics, regulatory aspects, mechanisms of action, health benefits for the host, optimal production processes, screening methods, (meta)genomics, proteomics, and metabolomics, host and bacterial physiology, application, and role in health and disease in man and animal. Beneficial Microbes is intended to serve the needs of researchers and professionals from the scientific community and industry, as well as those of policymakers and regulators.
https://www.wageningenacademic.com/loi/bm
×rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions.
Keep up-to-date with the latest microbiology news by getting our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.
Global Engage is a member of ISLA, a body established to accelerate the event industry transition to a sustainable future. As part of this, we are committed to selecting venues with more sustainable practices.
You can read the Hyatt 2030 environmental goals here.
We have reduced waste by replacing printed documentation with an app. Make sure you have it downloaded to your devices in time for the meeting. Get Agorify on Google Play and Apple App Store.
You will have some great food choices while you are with us but now we have worked with the caterer to increase the proportion of plant-based items. We have also built a plan with the venue to avoid waste through how they serve meals and how any leftovers are processed. Our aim is that you have some great meals, whilst with us, but with less environmental impact by the time you leave.
An international meeting does involve travel but where it is practical, please consider more sustainable alternatives to flying. The app will also have a discussion space to arrange ride shares.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.